Error: Could not add to watchlist. X

Trimel Pharmaceuticals Corp

+ Watchlist
TRL:CN
Toronto
0.70
CAD
0.02
2.94%
As of 15:01:52 ET on 07/02/2015.
Open
0.69
Day Range
0.68 - 0.70
Volume
22,330
Previous Close
0.68
52Wk Range
0.31 - 0.86
1 Yr Return
-1.41%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.10
Market Cap (m CAD)
140.611
Shares Outstanding (m)
200.873
Price/Sales (TTM)
14.62
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Trimel Pharmaceuticals Corp. is a pharmaceutical development company. The Company's primary objective is to exploit Trimel's drug-delivery technology portfolio and to target unmet medical needs in underserved disease states. Trimel's term objectives include the development of products for the treatment of male hypogonadism, female sexual dysfunction, and Parkinson's disease.
ADDRESS
2488 Dunwin Drive
Mississauga, ON L5L 1J9
Canada
PHONE
1-416-679-0899
  • Tom Rossi
    President/CEO
  • Kenneth G Howling
    Chief Financial Officer
  • Hubert Czerwinski
    Pres:Trimel Biopharma SRL
  • Nathan John Bryson
    VP:Scientific Affairs
  • Matthew Hawkins
    VP:Legal Affairs/Secretary
Show More